Covered recipient · General Payments record
JAMES WILLIAMS
Allopathic & Osteopathic Physicians Internal Medicine Infectious Disease
General Payments · PY2018–2024
$2,436.22
- Reported across 83 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $720.77 | 27 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| MIMEDX Group, Inc. | $310.15 | 6 |
| Insmed, Inc. | $150.29 | 10 |
| Gilead Sciences, Inc. | $73.31 | 2 |
| ABBVIE INC. | $72.91 | 4 |
| ORGANOGENESIS INC. | $44.29 | 2 |
| Retrophin, Inc. | $29.87 | 1 |
| Merck Sharp & Dohme Corporation | $22.34 | 1 |
| Integra LifeSciences Corporation | $17.61 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (27)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $18.54 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106341205 | CMS |
| ABBVIE INC. | $17.13 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106341207 | CMS |
| ABBVIE INC. | $18.95 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106341209 | CMS |
| ABBVIE INC. | $18.29 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106341211 | CMS |
| Gilead Sciences, Inc. | $47.63 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133843200 | CMS |
| Gilead Sciences, Inc. | $25.68 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133843202 | CMS |
| Insmed, Inc. | $21.01 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089566001 | CMS |
| Insmed, Inc. | $17.86 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089565997 | CMS |
| Insmed, Inc. | $17.97 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089565993 | CMS |
| Insmed, Inc. | $11.41 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089565983 | CMS |
| Insmed, Inc. | $22.06 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089565999 | CMS |
| Insmed, Inc. | $2.84 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089565985 | CMS |
| Insmed, Inc. | $7.64 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089565989 | CMS |
| Insmed, Inc. | $19.62 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089565987 | CMS |
| Insmed, Inc. | $9.61 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089565991 | CMS |
| Insmed, Inc. | $20.27 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089565981 | CMS |
| Integra LifeSciences Corporation | $17.61 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140101588 | CMS |
| Merck Sharp & Dohme LLC | $22.34 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141609375 | CMS |
| MIMEDX Group, Inc. | $19.92 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140272016 | CMS |
| MIMEDX Group, Inc. | $123.61 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140272018 | CMS |
| MIMEDX Group, Inc. | $24.35 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140272020 | CMS |
| MIMEDX Group, Inc. | $29.05 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140272022 | CMS |
| MIMEDX Group, Inc. | $91.72 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140272024 | CMS |
| MIMEDX Group, Inc. | $21.50 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140272026 | CMS |
| Organogenesis Inc. | $21.17 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145452235 | CMS |
| Organogenesis Inc. | $23.12 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145452237 | CMS |
| Travere Therapeutics, Inc. | $29.87 | 05/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149913560 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.